The 12th Joint Conference of Taiwan and Japan on Medical Products Regulation on October 7th, 2024.
Safety Classified by Officially
Taiwan Food and Drug Administration (TFDA) collaborates with Japan’s Ministry of Health, Labour, and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) to host the 12th Joint Conference of Taiwan and Japan on Medical Products Regulation on October 7th, 2024 in Tokyo, Japan. The conference aims to facilitate the exchange of regulatory information, promote cooperation between officials and industries from both sides, and support industry growth in international markets, all while prioritizing public health and well-being. Since the “Framework of Cooperation on Medical Products Regulation” was signed by the Taiwan-Japan Relations Association and Japan-Taiwan Exchange Association in November 2013, both sides have alternated hosting Joint Conferences annually for 12 years. This year, representatives from TFDA, MHLW and PMDA will share the latest information on medical product regulations, as well as discuss important topics such as “Improving patient access to innovative drugs and ensuring sustainable supply,” “Regulations on biosimilar products,” and “Latest updates on CADe/CADx medical device review requirements and recent innovations and developments.” The confer...
Read the original at the source: http://www.fda.gov.tw/eng/newsContent.aspx?id=30770&utm_source=rss&utm_medium=feed&utm_campaign=rss_subscription
Officially imported this from Taiwan Food and Drug Administration’s own source. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Taiwan Food and Drug Administration — imported from official source
- Official source
- https://www.fda.gov.tw/ENG/rssNews.ashx RSS
- Imported
- October 06, 2026 16:34
- Versions
- 1 recorded
- Identity
-
https://www.fda.gov.tw/eng/newsContent.aspx?id=30770&utm_source=rss&utm_medium=feed&utm...